Quantitative scintigraphic parameters for the assessment of renal transplant patients

European Journal of Radiology

Volumn 28, Issue 3, 1998, Pages 256-269

  El Maghraby, T A F ^a   Van Eck Smit, B L F ^a   De Fijter, J W ^a   Pauwels, E K J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Perfusion index; Renal scintigraphy; Renal transplant

Indexed keywords

BLOOD VESSELS; COMPUTATIONAL METHODS; DRUG THERAPY; GRAFTS;

PERFUSION INDEX; RENAL SCINTIGRAPHY; RENAL TRANSPLANT;

DIAGNOSTIC RADIOGRAPHY;

ARTICLE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HUMAN; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; KIDNEY PERFUSION; KIDNEY SCINTISCANNING; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL;

HUMANS; IODINE RADIOISOTOPES; IODOHIPPURIC ACID; KIDNEY TRANSPLANTATION; RADIOISOTOPE RENOGRAPHY; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M MERTIATIDE; TECHNETIUM TC 99M PENTETATE;

EID: 0032192539     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0720-048X(97)00179-4     Document Type: Article

References (74)

1. [1] Kountz SL, Truex G, Earley LE, Beizer FO. Serial hemodynamics after renal allotransplantation in man. Circulation 1970;41:217-24.
2. [2] Taplin GV, Dore EK, Johnson DE. The quantitative radiorenogram for total and differential renal blood flow measurements. J Nucl Med 1963;4:404-9.
3. [3] Dunn EK. Radioisotopic evaluation of renal transplants. Urol Radiol 1992;14:115-26.
4. [4] Hamilton D, Miola UJ, Payne MC. The renal transplant perfusion index: reduction in the error and variability. Eur J Nucl Med 1994;21:232-8.
5. [5] Oei HY. Dynamic and static renal imaging. In: Murray IPC, Ell PJ, editors. Nuclear Medicine in Clinical Diagnosis and Treatment, vol. 1. Edinburgh: Churchill Livingstone, 1994:213-27.
6. [6] Kirchner PT, Gray F, Short D, et al. Correlation of gamma camera and flow meter determined renal blood flow measurements (Abstract). J Nucl Med 1974;15:506.
7. [7] Dubovsky EV, Logic JR, Diethelm AG, Balch CM, Tauxe WN. Comprehensive evaluation of renal function in the transplanted kidney. J Nucl Med 1975;16:1115-20.
8. [8] Hilson AJ, Maisey MN, Brown CB, Ogg CS, Bewick MS. Dynamic renal transplant imaging with Tc-99m DTPA (Sn) supplemented by a transplant perfusion index in the management of renal transplants. J Nucl Med 1978;19:994-1000.
9. [9] Preston DF, Luke RG. Radionuclide evaluation of renal transplants. J Nucl Med 1979;20:1095-7.
10. [10] George EA. Radionuclide diagnosis of allograft rejection. Semin Nucl Med 1982;12:379-86.
11. [11] Kirchner PT, Goldman MH, Leapman SB, Kiepfer RF. Clinical application of the kidney to aortic blood flow index (K/A ratio). Contrib Nephrol 1978;11:120-6.
12. [12] Williams DL. Improvement in quantitative data analyses by numerical deconvolution techniques. J Nucl Med 1979;20:568-70.
13. [13] Tauxe WN, Dubovsky EV. Nuclear Medicine in Clinical Urology and Nephrology. New York: Appleton-Century-Crofts, 1985:91-2.
14. [14] Peters AM, Gunasekera RD, Henderson BL, Brown J, Lavender JP, De Souza M, Ash JM, Gilday DL. Noninvasive measurement of blood flow and extraction fraction. Nucl Med Commun 1987;8:823-37.
15. [15] Bubeck B, Brandau W, Weber E, Pomer S, Georgi P, zum Winkel K. Renal function studies using 99mTc-MAG3: pharmacokinetics and slope clearance determination. Contrib Nephrol 1990;79:72-3.
16. [16] Kirchner PT, Rosenthall L. Renal transplant evaluation. Semin Nucl Med 1982;12:370-8.
17. [17] Conrad GR, Wesolowski CA, Berbaum KS, Jensen KC, Kirchner PT. Renal arteriovenous transit times of technetium-radiolabeled chelates. J Nucl Med 1987;28:1134-43.
18. [18] Groothedde RT, Koppejan LJ, Heidendal GK, Hasman A. The differential ratio. A method for describing blood flow in renal transplants. Nucl Med Commun 1990;11:771-6.
19. [19] Riedinger Berriolo A, Touzery C, Chevet D, Toubeau M, Riedinger JM, Mezeray C, Brunotte F. Normal range of [99mTc]MAG-3 renogram parameters in renal transplant recipients. Transplant Proc 1994;26:301-2.
20. [20] Russell CD, Thorstad BL, Yester MV, Stutzman M, Dubovsky EV. Quantitation of renal function with technetium-99m MAG3. J Nucl Med 1988;29:1931-3.
21. [21] Ellam SV, Maisey MN, Mistry R. Measurement of changes of blood flow in renal transplants. Eur J Nucl Med 1983;8:84-6.
22. [22] Gedroyc W, Taube D, Fogleman I, Neild G, Cameron S, Maisey M. Tc-99m DTPA scans in renal allograft rejection and cyclosporine nephrotoxicity. Transplantation 1986;42:494-7.
23. [23] Anaise D, Oster ZH, Atkins HL, Arnold AN, Weis S, Waltzer WC, Rapaport FT. Cortex perfusion index: a sensitive detector of acute rejection crisis in transplanted kidneys. J Nucl Med 1986;27:1697-701.
24. [24] George EA, Salimi Z, Wolverson MK, Garvin PJ. Assessment of renal allograft pathology by scintigraphic and ultrasound index-markers. Clin Nucl Med 1991;16:394-8.
25. [25] Al-Nahhas AM, Kedar R, Morgan SH, Landells WN, al Murrani B, Heary T, Wright A, Cosgrove DO, Bending MR, McCready VR. Cellular versus vascular rejection in transplant kidneys. Correlation of radionuclide and Doppler studies with histology. Nucl Med Commun 1993;14:761-5.
26. [26] Fraile M, Castell J, Buxeda M, Cuartero A, Cantarell C, Domenech Torne FM. Transplant renography: 99m-Tc-DTPA versus 99m-Tc-MAG3. A preliminary note. Eur J Nucl Med 1989;15:776-9.
27. [27] Oriuchi N, Miyamoto K, Hoshino K, Imai J, Takahashi Y, Sakai S, Shimada A, Endo K. Tc-99m MAG3: A sensitive indicator for evaluating perfusion and rejection of renal transplants. Nucl Med Commun 1997;18:400-4.
28. [28] Brown NJ, Britton KE. The renogram and its quantitation. Br J Urol 1969;42:15-25.
29. [29] Russell CD. Measurement and interpretation of renal transit times. In: Murray IPC, Ell PJ, editors. Nuclear Medicine in Clinical Diagnosis and Treatment. Edinburgh: Churchill Livingstone, 1994:241-5.
30. [30] Rutland MD. Mean transit times without deconvolution. Nucl Med Commun 1981;2:337-44.
31. [31] Schmidlin P, Clorius JH, Lubosch E-M, Siems H, Boehm M, Dreikorn K. Renal perfusion and mean vascular transit time. Eur J Nucl Med 1985;11:69-72.
32. [32] Chaiwatanarat T, Laorpatanaskul S, Poshyachinda M, Boonvisut S, Buachum V, Krisanachinda A, Suvanapha R. Deconvolution analysis of renal blood flow: evaluation of postrenal transplant complications. J Nucl Med 1994;35:1792-6.
33. [33] Peters AM, Brown J, Hartnell GG, Myers MJ, Haskell C, Lavender JP. Non-invasive measurement of renal blood flow with 99mTc DTPA: comparison with radiolabelled microspheres. Cardiovasc Res 1987;21:830-4.
34. [34] Peters AM. Quantification of renal haemodynamics with radionuclides. Eur J Nucl Med 1991;18:274-86.
35. [35] Ash J, DeSouza M, Peters M, Wilmot D, Hausen D, Gilday D. Quantitative assessment of blood flow in pediatric recipients of renal transplants. J Nucl Med 1990;31:580-5.
36. [36] Hayes M, Moore TC. Early detection and classification of renal transplant rejection by B-K scan ratio and blood isotope clearance data. Transplantation 1971;12:139-41.
37. [37] Hayes M, Moore TC, Taplin GV. Radionuclide procedures in predicting early renal transplant rejection. Radiology 1972;103:627-31.
38. 131I hippurate blood clearance and bladder-kidney ratio data in the early detection, classification, and management of accelerated rejection of human renal transplants. Surgery 1974;76:587-600.
39. [39] Rosenthall L, Mangel R, Lisbona R, Lacourciere Y. Diagnostic applications of radiopertechnetate and radiohippurate imaging in post-renal transplant complications. Radiology 1974;111:347-58.
40. 131I-Hippuran and sequential scintillation camera image. Br J Radiol 1975;48:768.
41. [41] Oei HY, Ephraim KH, Jessurun RFM, Neiuwenhuis MG, Struyvenberg A. In: Hollenberg NK, Lange S, editors. Radionuclides in Nephrology. Stuttgart: Thieme, 1980:251.
42. [42] Dubovsky EV, Russell CD, Yester MV, Thorstad BL, Ryan JP. Will 99mTc-MAG3 replace 131I-OIH and 99mTc-DTPA in the follow-up of renal transplants? Contrib Nephrol 1990;79:118-22.
43. [43] Tauxe WN, Maher FT, Taylor WF. Effective renal plasma flow: estimation from theoretical volumes of distribution of intravenously injected 131-I orthoiodohippurate. Mayo Clin Proc 1971;46:524-31.
44. [44] Myers BD, Miller DC, Mehigan JT, Olcott CO, Golbetz H, Robertson CR, Derby G, Spencer R, Friedman S. Nature of the renal injury following total renal ischemia in man. J Clin Invest 1984;73:329-41.
45. [45] Bubeck B. Quantitative evaluation of clearance. In: Murray IPC, Ell PJ, editors. Nuclear Medicine in Clinical Diagnosis and Treatment, vol. 1. Edinburgh: Churchill Livingstone, 1994:229-39.
46. [46] Blaufox MD, Potchen EJ, Merrill JP. Measurement of effective renal plasma flow in man by external counting methods. J Nucl Med 1967;8:77-85.
47. [47] Schlegel JU, Hamway SA. Individual renal plasma flow determination in 2 min. J Urol 1976;116:282-5.
48. [48] Gates GF. Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous). Am J Roentgenol 1982;138:565-70.
49. [49] Nankivell BJ, Gruenewald SM, Allen RD, Chapman JR. Predicting glomerular filtration rate after kidney transplantation. Transplantation 1995;59:1683-9.
50. [50] Jelliffe RW. Letter: Creatinine clearance: bedside estimate. Ann Intern Med 1973;79:604-5.
51. [51] Jackson JH, Blue PW, Ghaed N. Glomerular filtration rate determined in conjunction with routine renal scanning. Radiology 1985;154:203-5.
52. [52] Kamper AL, Nielsen SL. 51Cr-EDTA plasma clearance in severe renal failure determined by one plasma sample. Scand J Clin Lab Invest 1989;49:555-9.
53. [53] Reinig JW, Gordon L, Frey D, Garrick E, Daniel WTd. Glomerular filtration rate in transplantation patients: estimation of renal function using Tc-99m DTPA. Radiology 1985;156:505-7.
54. [54] Diethelm AG, Dubovsky EV, Whelchel JD, Hartley MW, Tauxe WN. Diagnosis of impaired renal function after kidney transplantation using renal scintigraphy, renal plasma flow and urinary excretion of hippurate. Ann Surg 1980;191:604-16.
55. [55] Bajen MT, Martin Comin J, Puchal R, Grino JM, Roca M, Segarra I, Castelao AM, Castell M, Ramos M. 99mTc-MAG-3 activity indices in kidney grafts. Transplant Proc 1992;24:60.
56. [56] Bajen MT, Martin Comin J, Gonzalez A, Castelao AM, Grino JM, Roca M, Mora J, Puchal R. 99mTc-MAG3 renogram deconvolution analysis as a diagnostic aid in kidney graft monitoring. Transplant Proc 1995;27:2221.
57. [57] Dubovsky EV, Russell CD, Erbas B. Radionuclide evaluation of renal transplants. Semin Nucl Med 1995;25:49-59.
58. [58] Farmelant MH, Bakos K, Burrows BA. Physiological determinants of renal tubular passage times. J Nucl Med 1969;10:641-5.
59. [59] Piepsz A, Ham HR, Erbsmann F, Hall M, Diffey BL, Goggin MJ, Hall FM, Miller JA, Lumbroso J, Di Paola R, Bazin JP, Di Paola M, Fries D. A co-operative study on the clinical value of dynamic renal scanning with deconvolution analysis. Br J Radiol 1982;55:419-33.
60. [60] McConnell JD, Sagalowsky AI, Lewis SE, Gailiunas P, Helderman JH, Dawidson I, Peters PC. Prospective evaluation of renal allograft dysfunction with Technetium-99m-diethylenetriamine-pentaacetic acid renal scans. J Urol 1984;131:875-9.
61. [61] Rutland MD. A comprehensive analysis of renal DTPA studies. II. Renal transplant evaluation. Nucl Med Commun 1985;6:21-30.
62. [62] Hayashi I. Usefulness of radioisotope (RI) deconvolution analysis with Tc-99m-DTPA in transplanted kidney. Kakuigaku 1989;26:1193-7.
63. [63] Kubota K, Atkins HL, Anaise D, Oster ZH, Pollack W. Quantitative evaluation of renal excretion on the dynamic DTPA renal scan. Clin Nucl Med 1989;14:8-12.
64. [64] Russell CD, Yester MV, Dubovsky EV. Measurement of renal parenchymal transit time of 99mTc-MAG3 using factor analysis. Nuklearmedizin 1990;29:170-6.
65. [65] Gonzalez A, Puchal R, Bajen MT, Mairal L, Prat L, Martin Comin J. 99Tcm-MAG3 renogram deconvolution in normal subjects and in normal functioning kidney grafts. Nucl Med Commun 1994;15:680-4.
66. [66] Mizuiri S, Hayashi I, Takano M, Ban R, Ohara T, Sasaki Y, Hasegawa A. Fractional mean transit time in transplanted kidneys studied by technetium-99m-DTPA: comparison of clinical and biopsy findings. J Nucl Med 1994;35:84-9.
67. [67] O'Malley JP, Ziessman HA, Chantarapitak N. Tc-99m MAG3 as an alternative to Tc-99m DTPA and 1-131 Hippuran for renal transplant evaluation. Clin Nucl Med 1993;18:22-9.
68. 131I-OIH and 99mTc-DTPA in the follow-up of renal transplants? Contrib Nephrol 1990;79:118-22.
69. [69] Bischof-Delaloye A, Wauters JP, Delaloye B. I-131 hippuran renography: Accumulation and elimination indices in the long term follow-up of renal transplants. In: Joekes AM, Brown NJG, Tauxe WN, editors. Radionuclides in Nephrology. London: Academic Press, 1982:289-94.
70. [70] Oei HY, Ephraim KH, Jessurun RFM, Struyvenberg A. The value of renal scintigraphy for the differential diagnosis of complications after renal transplantation. In: Joekes AM, Brown NJG, Tauxe WN, editors. Radionuclides in Nephrology. London: Academic Press, 1982:283-8.
71. [71] Oei HY, Surachno S, Wilmink JM, van der School JB. Measurements of 99mTc-MAG3 uptake in renal transplant recipients. Contrib Nephrol 1990;79:113-7.
72. [72] Dubovsky EV, Tauxe WN, Diethelm AG, Whelchel JD, Rivera R, Yester M. Dynamic patterns of kidney transplant complications using quantitative functional evaluation. In: Joekes AM, Brown NJG, Tauxe WN, editors. Radionuclides in Nephrology. London: Academic Press, 1982:257-62.
73. [73] Yi L, Russell CD, Palmer-Lawrence J, Dubovsky EV. Quantitation of renal parenchymal retention of Tc-99m MAG-3 in renal transplants. J Nucl Med 1994;35:846-50.
74. [74] Russell CD, Palmer-Lawrence JL, Dubovsky EV. Two measures of parenchymal retention of I-131-iodohippurate (OIH) or Tc-99m-MAG3 in transplanted kidneys (Abstract). J Nucl Med 1990;31(Suppl):716.